Stock AUPH AURINIA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Aurinia Pharmaceuticals Inc.

Equities

AUPH

CA05156V1022

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
5.42 USD +0.74% Intraday chart for Aurinia Pharmaceuticals Inc. +4.03% -39.71%
May. 14 Aurinia Pharmaceuticals Inc. Presented Results from the Analysis Showing Lupkynis A Cost-Effective Treatment for Lupus Nephritis Presented At National Kidney Foundation's Spring Clinical Meeting 2024 CI
May. 07 Lucien Selce Urges Aurinia Pharmaceuticals Board to Take Action to Enhance Shareholder Value CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AURINIA PHARMACEUTICALS INC. Stock Aurinia Pharmaceuticals Inc.
 773M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. AUPH Stock
  4. Charts Aurinia Pharmaceuticals Inc.
  5. Sector Chart